Dosimetric parameters correlate with duodenal histopathologic damage after stereotactic body radiotherapy for pancreatic cancer: Secondary analysis of a prospective clinical trial.
about
Quantification of renal function following stereotactic body radiotherapy for pancreatic cancer: secondary dosimetric analysis of a prospective clinical trial.Biological determinants of radioresistance and their remediation in pancreatic cancer.Feasibility and reproducibility of substituting oral contrast with water for duodenal volume delineation in patients undergoing pancreatic stereotactic body radiotherapy.Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients.Health-related quality of life for gemcitabine and nab-paclitaxel plus radiotherapy versus gemcitabine and S-1 plus radiotherapy in patients with metastatic pancreatic cancer
P2860
Dosimetric parameters correlate with duodenal histopathologic damage after stereotactic body radiotherapy for pancreatic cancer: Secondary analysis of a prospective clinical trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Dosimetric parameters correlat ...... a prospective clinical trial.
@en
Dosimetric parameters correlat ...... a prospective clinical trial.
@nl
type
label
Dosimetric parameters correlat ...... a prospective clinical trial.
@en
Dosimetric parameters correlat ...... a prospective clinical trial.
@nl
prefLabel
Dosimetric parameters correlat ...... a prospective clinical trial.
@en
Dosimetric parameters correlat ...... a prospective clinical trial.
@nl
P2093
P2860
P1476
Dosimetric parameters correlat ...... a prospective clinical trial.
@en
P2093
Aaron R Sasson
Abhijeet R Bhirud
Audrey J Lazenby
Chandrakanth Are
Dandan Zheng
Vivek Verma
P2860
P304
P356
10.1016/J.RADONC.2016.12.030
P577
2017-01-12T00:00:00Z